内体
NPC1
尼曼-皮克病,C型
体内
尼曼-皮克病
细胞生物学
神经系统
溶酶体贮存病
中枢神经系统
生物
神经节苷脂
溶酶体
细胞内
神经科学
胆固醇
化学
生物化学
酶
遗传学
作者
Amélie Barthelemy,Valérie Demais,Izabela‐Cristina Stancu,Eugeniu Vasile,Tom Houben,Michaël Reber,Valentina Pallottini,Martine Perraut,Sophie Reibel,Frank W. Pfrieger
标识
DOI:10.1016/j.nbd.2021.105469
摘要
Niemann-Pick type C disease is a rare and fatal lysosomal storage disorder presenting severe neurovisceral symptoms. Disease-causing mutations in genes encoding either NPC1 or NPC2 protein provoke accumulation of cholesterol and other lipids in specific structures of the endosomal-lysosomal system and degeneration of specific cells, notably neurons in the central nervous system (CNS). 2-hydroxypropyl-beta-cyclodextrin (CD) emerged as potential therapeutic approach based on animal studies and clinical data, but the mechanism of action in neurons has remained unclear. To address this topic in vivo, we took advantage of the retina as highly accessible part of the CNS and intravitreal injections as mode of drug administration. Coupling CD to gold nanoparticles allowed us to trace its intracellular location. We report that CD enters the endosomal-lysosomal system of neurons in vivo and enables the release of lipid-laden lamellar inclusions, which are then removed from the extracellular space by specific types of glial cells. Our data suggest that CD induces a concerted action of neurons and glial cells to restore lipid homeostasis in the central nervous system.
科研通智能强力驱动
Strongly Powered by AbleSci AI